With operations in 35+ nations and ~27,000 employees worldwide, CSL is driven to develop and deliver a broad range of lifesaving therapies to treat disorders such as hemophilia and primary immune deficiencies, and vaccines to prevent influenza. Our therapies are also used in cardiac surgery, organ transplantation and burn treatment.
CSL is the parent company of CSL Behring and Seqirus. CSL Behring is a global leader in the protein biotherapeutics industry, focused on bringing to market biotherapies used to treat serious and often rare conditions. CSL Behring operates CSL Plasma, one of the world's largest collectors of human plasma, which is used to create CSL’s therapies. Seqirus is one of the largest influenza vaccine companies in the world and is a transcontinental partner in pandemic preparedness and a major contributor to the prevention and control of influenza globally.
We invite you to take a look at the many career possibilities available around the globe and consider building your promising future at CSL by becoming a member of our team!
This role will develop and implement strategies that optimize the immunization policy settings for Seqirus in the US market, supporting the success of the business and achieving multi-stakeholder goals for improved influenza prevention. The role will drive an influenza policy agenda at the federal level, building strong stakeholder networks and leading broad policy engagement based on shared public health interests. The role will be responsible for identifying strategic immunization policy risks and opportunities, and providing analysis, insights and recommended strategies to Seqirus teams. As a key member of the Seqirus US policy team, the role will work closely with the Director US Federal Government Affairs and Director US State Policy & Government Affairs, as well as the US Medical Affairs and Communications teams to support the US Commercial organization to achieve business growth and improved public health outcomes.
- Builds strong relationships, networks and partnerships with US policy stakeholders including coalitions, advocacy groups and professional societies, to drive an influenza policy agenda.
- Develops and leads efforts to maintain and grow advocacy policy contacts and network including, but not limited to, NFID, IAC, AIM, BIO and IDSA.
- Develops and implements strategies to shape immunization policy outcomes that support differentiation and influenza vaccine uptake in the US.
- Identifies and analyzes strategic immunization policy risks and opportunities, providing policy insights and solutions to US commercial and policy leadership.
- Partners with the US policy team to leverage Congressional activity across the federal stakeholder network and support engagement at the State level.
- Drives the US grants process to foster research, evidence-based programs and education that support our policy ambitions and strengthen our stakeholder network.
- Develops relevant submissions, position papers and policy materials tailored to the US immunization environment, coordinating input from internal experts.
- Ensures compliance with industry Codes and the Seqirus approval process for grants, submissions, presentations and other materials used in policy outreach.
- Contributes to global policy and government affairs strategies for Seqirus and CSL policy teams.
- Collaborates with the Communications team to amplify policy messaging and contribute content for use in Seqirus-owned internal and external platforms and channels.
- Serves as an expert resource on public policy, advocacy engagement, health systems and immunization programs, and stakeholder influence.
- Represents Seqirus on Corporate Boards, industry organizations, and advocacy initiatives.
- Bachelor’s degree or Master’s degree in political science, public policy, public health or MBA/JD would be an advantage.
- At least 10 years’ experience in advocacy, policy and government affairs roles in the vaccines sector, preferably in large, complex organizations and in government. Additional experience in professional societies and advocacy groups would be advantage.
- Demonstrated ability to collaborate across a matrixed organization and drive outstanding commercial results through effective policy and advocacy strategies.
- Deep knowledge and nuanced understanding of the US vaccines landscape and related advocacy ecosystem, the healthcare environment in the US, and the workings of US governments.
- Strong business acumen with the ability to grasp the implications and act on complex and multi-dimensional issues that impact the vaccines industry and Seqirus.
- Well-established stakeholder relationships and networks with key decision makers, opinion leaders and advocacy groups in the influenza community in US.
- Outstanding written and verbal communications skills with the ability to represent and speak on behalf of Seqirus in high level meetings and in public forums
- Excellent organizational, planning and project management skills involving cross functional teams.